2.22 USD
↘ 0.31 (12.30%)AT CLOSE (11:59 AM EDT)
Acumen Pharmaceuticals, Inc. Common Stock
ABOSNASDAQ • USD
2.24
↗ 0.01 (0.68%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
2.24
↗ 0.01 (0.68%)
Market: CLOSED
Shares of Acumen Pharmaceuticals, Inc. Common Stock (ABOS) are trading at $2.21. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest ABOS is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jul 15, 2026.
Open?$2.54
High?$2.55
Low?$2.20
Prev. Close?$2.53
Volume?676.2K
Avg. Volume?583.2K
VWAP?$2.30
Rel. Volume?1.16x
Bid / Ask
Bid?$1.90 × 100
Ask?$2.62 × 100
Spread?$0.72
Midpoint?$2.26
Valuation & Ratios
Market Cap?182.7M
Shares Out?72.2M
Float?37.4M
Float %?51.8%
P/E Ratio?N/A
P/B Ratio?2.09
EPS?-$1.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Employees
61
Market Cap
182.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-07-01
Address
1210-1220 WASHINGTON STREET
NEWTON, MA 02465
Phone: 617-344-4190
NEWTON, MA 02465
Phone: 617-344-4190
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.42Distress
Confidence?41%Low
Short InterestElevated
Short % of Float?7.45%Elevated
Short Interest?2.8M
Days to Cover?2.6
Free Float37.4M
Avg Daily Volume1.1M
Settlement Date2026-06-30
Financial Health
Current Ratio?4.55Strong
Quick Ratio?4.55Strong
Cash Ratio?1.77Strong
Debt/Equity?0.35Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.09CHEAP▾
Peers100
S&P72
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-129.5%WEAK▾
S&P3
ROA?-84.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-105554000
Enterprise Value?$162.0M
Fundamentals ratios updated end of day